A prospective, observational study evaluating safety of prasugrel in real-world patients with ST-segment elevation myocardial infarction (STEMI).

Trial Profile

A prospective, observational study evaluating safety of prasugrel in real-world patients with ST-segment elevation myocardial infarction (STEMI).

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel; Vitamin K antagonists
  • Indications Myocardial infarction
  • Focus Adverse reactions
  • Acronyms Bleed-MI
  • Most Recent Events

    • 28 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top